At a time when a particularly large number of drugs are being tested in studies, such as the current COVID 19 pandemic, the number of different primary packaging is increasing. This is because the large number of different ampoule and vial sizes requires new packaging designs time and again. "For many manufacturers, this is a rather tiresome and cost-intensive issue. What's more, the different types of packaging take up a lot of storage space," says Joachim Hoeltz, Chief Executive Officer Packaging Materials in the Körber Business Area Pharma. "Our long-standing customer UCB therefore approached us with the idea of finding a sustainable solution to this issue together.
One packaging solution for different medicines
Product developer Cecile Zimmermann and the innovation team for packaging materials from the Business Area Pharma developed a secondary packaging consisting of two units: an inner and an outer box. Thanks to flexible tabs in the inner box, different product sizes can be securely packed in just one packaging solution. The products are optimally fixed and protected regardless of their size. Pharmaceutical manufacturers can thus reduce the large number of secondary packages to a minimum.
"Together with UCB, we have found a solution that is unique and takes a real load off our customers' shoulders," says Hoeltz. "They can now concentrate fully on developing and testing new products."
Winning the European Carton Excellence Award is already the second major award this year in this area for Körber: At the beginning of the year, the team also won the Pharmapack Award for its Smart Package. The intelligent drug packaging serves as a communication medium with the patient and offers him or her a gateway to valuable information and services in the digital world.
Further information on the sustainable packaging solutions of Körber's Business Area Pharma is available to interested parties.
